
NASDAQ:AMRI • US0124231095
The current stock price of AMRI is 21.74 null. Today AMRI is down by 0%. In the past month the price increased by 0.23%. In the past year, price increased by 48.4%.
ChartMill assigns a technical rating of 8 / 10 to AMRI. When comparing the yearly performance of all stocks, AMRI is one of the better performing stocks in the market, outperforming 87.04% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to AMRI. AMRI may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months AMRI reported a non-GAAP Earnings per Share(EPS) of -1.42. The EPS decreased by -46.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -8.78% | ||
| ROA | -4.81% | ||
| ROE | -18.86% | ||
| Debt/Equity | 0.62 |
Albany Molecular Research is an integrated provider of drug discovery and development, chemistry research and manufacturing services. They offer services traditionally provided by chemistry divisions within pharmaceutical and biotechnology companies, including drug discovery, medicinal chemistry, chemical development, analytical chemistry services and small-scale and pilot-plant manufacturing. Recently, they expanded their service offerings to include commercial manufacturing through their strategic relationship with and investment in Organichem Corporation.
ALBANY MOLECULAR RESH INC
26 CORPORATE CIRCLE
ALBANY NY 12212
CEO: William S. Marth
Phone: 518-512-2000
Albany Molecular Research is an integrated provider of drug discovery and development, chemistry research and manufacturing services. They offer services traditionally provided by chemistry divisions within pharmaceutical and biotechnology companies, including drug discovery, medicinal chemistry, chemical development, analytical chemistry services and small-scale and pilot-plant manufacturing. Recently, they expanded their service offerings to include commercial manufacturing through their strategic relationship with and investment in Organichem Corporation.
The current stock price of AMRI is 21.74 null.
AMRI does not pay a dividend.
AMRI has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
ALBANY MOLECULAR RESH INC (AMRI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.42).